<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ayu</journal-id><journal-id journal-id-type="iso-abbrev">Ayu</journal-id><journal-id journal-id-type="publisher-id">AYU</journal-id><journal-title-group><journal-title>Ayu</journal-title></journal-title-group><issn pub-type="ppub">0974-8520</issn><issn pub-type="epub">0976-9382</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26730138</article-id><article-id pub-id-type="pmc">4687238</article-id><article-id pub-id-type="publisher-id">AYU-36-46</article-id><article-id pub-id-type="doi">10.4103/0974-8520.169008</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>A comparative clinical study on the effect of <italic>Tagara</italic> (<italic>Valeriana wallichii</italic> DC.) and <italic>Jatamansi</italic> (<italic>Nardostachys jatamansi</italic> DC.) in the management of <italic>Anidra</italic> (primary insomnia)</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Toolika</surname><given-names>E.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Bhat</surname><given-names>Narayana Prakash</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Shetty</surname><given-names>Suhas Kumar</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib></contrib-group><aff id="aff1">Chulliparambil Nursing Home, Perinjanam, Thrissur, Kerala, India</aff><aff id="aff2"><label>1</label>Department of Kaya Chikitsa Manasa Roga, Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan, Karnataka, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Toolika E. Eranezhath House, P.O. Nattika, Thrissur - 680 566, Kerala, India. E-mail: <email xlink:href="toolikaajay@gmail.com">toolikaajay@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2015</year></pub-date><volume>36</volume><issue>1</issue><fpage>46</fpage><lpage>49</lpage><permissions><copyright-statement>Copyright: &#x000a9; AYU (An International Quarterly Journal of Research in Ayurveda)</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Introduction:</title><p>The World Health Organization's 2004 Global Burden of Disease report indicated 3.6 million years of productive, healthy life is lost worldwide as a result of primary insomnia. Approximately 30&#x02013;35% of people meet diagnostic criteria for primary insomnia characterized by impairment resulting from problems of falling and staying asleep.</p></sec><sec id="st2"><title>Aims:</title><p>To evaluate the effect of <italic>Tagara</italic> (<italic>Valeriana wallichii</italic> DC.) and <italic>Jatamansi</italic> (<italic>Nardostachys jatamansi</italic> DC.) in the management of <italic>Anidra</italic>.</p></sec><sec id="st3"><title>Materials and Methods:</title><p>A total of 34 patients were selected fulfilling the criteria for inclusion for primary insomnia were randomly selected from Out Patient Department and In Patient Department of <italic>Manasa Roga</italic> and assigned into two groups, wherein 30 patients completed the study (15 in each). <italic>Tagara Churna</italic> (powder of <italic>V. wallichii</italic>) and <italic>Jatamansi Churna</italic> (powder of <italic>N. jatamansi</italic>) in the dose of 4 gm with milk was administered three times a day for a period of 1 month.</p></sec><sec id="st4"><title>Results:</title><p><italic>Tagara</italic> provided significant improvement in initiation of sleep (76.00%; <italic>P</italic> &#x0003c; 0.001), duration of sleep (55.17%; <italic>P</italic> &#x0003c; 0.001), disturbed sleep (69.58%; <italic>P</italic> &#x0003c; 0.001), and disturbances in routine work (73.95%; <italic>P</italic> &#x0003c; 0.001). <italic>Jatamansi</italic> provided improvement in initiation of sleep (61.34%; <italic>P</italic> &#x0003c; 0.001), duration of sleep (48.25%; <italic>P</italic> &#x0003c; 0.001), disturbed sleep (53.08%; <italic>P</italic> &#x0003c; 0.001), and disturbance in routine works (43.85%; <italic>P</italic> &#x0003c; 0.001).</p></sec><sec id="st5"><title>Conclusion:</title><p>Both the groups showed good results, but <italic>Tagara</italic> group showed better results in comparison to <italic>Jatamansi</italic> group.</p></sec></abstract><kwd-group><kwd><italic>Anidra</italic></kwd><kwd><italic>Jatamansi Churna</italic></kwd><kwd><italic>Nardostachys jatamansi</italic></kwd><kwd>primary insomnia</kwd><kwd><italic>Tagara Churna</italic></kwd><kwd><italic>Valeriana wallichii</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p><italic>Aahara</italic> (food), <italic>Nidra</italic> (sleep), and <italic>Brahmacharya</italic> (abstinence) are described to be the <italic>Trayopasthambhas</italic> (three supportive pillars) of life[<xref rid="ref1" ref-type="bibr">1</xref>] and so, sleep is one of the essential factors to lead a healthy life. It has been rightly stated by Acharya Charaka that happiness and misery, proper and improper growth, good strength and weakness, potency and sterility, knowledge and ignorance, and life and death of an individual depend on the quality of sleep.[<xref rid="ref2" ref-type="bibr">2</xref>]</p><p>Human being spend at least one-third of their life in asleep.[<xref rid="ref3" ref-type="bibr">3</xref>] The importance of sleep is well accepted by modern science also because of its restorative, recuperative, and resting actions. Insomnia is a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired. Among the chronic insomniac patients, about 25% are suffering from primary insomnia.[<xref rid="ref4" ref-type="bibr">4</xref>]</p><p>In comparison to the therapeutic procedure of different systems of medicine, Ayurveda has a very good approach towards the treatment of <italic>Anidra</italic> (insomnia). a good number of single drugs too are described in Ayurvedic literatures which give relief from <italic>Anidra</italic>. <italic>Tagara</italic> and <italic>Jatamansi</italic> are included among the <italic>Nidrajanana</italic> (sedative and hypnotic) drugs in the classics.</p><p>By taking into consideration of the above facts, this comparative study was planned to evaluate the effect of <italic>Tagara</italic> (<italic>Valeriana wallichii</italic> DC.) and <italic>Jatamansi</italic> (<italic>Nardostachys jatamansi</italic> DC.) clinically in the management of <italic>Anidra</italic> (primary insomnia) and to compare the effect of both drugs in the management of <italic>Anidra</italic>.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><p>A total of 34 patients fulfilling the diagnostic criteria of <italic>Anidra</italic> (primary insomnia) were randomly selected and registered from the Out Patient Department and In Patient Department of <italic>Manasa Roga</italic>. The study was carried out after obtaining the ethical clearance of Institutional Ethics Committee (SDM/IEC/35/2010- 2011 dated 14-03-2011), and prior consent was taken from the patient for undertaking the study.</p><p>For diagnosis, a detailed medical history was taken and physical examination was done in detail according to both modern and Ayurvedic clinical methods. A detailed interview was conducted to elucidate sleep problems, social problems, and other areas of functioning, etc.</p><p>To assess the psychological intactness, the mental status examination was carried out. To confirm or exclude the other medical disorders, routine hematological and urine investigations were carried out. A special proforma was prepared with a gradation of symptoms and scoring was done by adopting Athens Insomnia Scale.[<xref rid="ref5" ref-type="bibr">5</xref>]</p><sec id="sec2-1"><title>Inclusion criteria</title><p>
<list list-type="bullet"><list-item><p>Patients of insomnia suffering up to 5 years duration</p></list-item><list-item><p>Patients of either sex, between the age group 15 and 45 years</p></list-item><list-item><p><italic>Anidra</italic> (insomnia) patients complaining of <italic>Angamarda</italic> (bodyache), <italic>Shirogaurava</italic> (heaviness in the head), <italic>Jrumbha</italic> (yawning), <italic>Jadyata</italic> (inactivity), <italic>Glani</italic> (exhaustion), <italic>Bhrama</italic> (giddiness), <italic>Apakti</italic> (indigestion).</p></list-item></list>
</p></sec><sec id="sec2-2"><title>Exclusion criteria</title><p>
<list list-type="bullet"><list-item><p><italic>Anidra</italic> (insomnia) due to other conditions such as <italic>Madatyaya</italic> (alcoholism), <italic>Abhighata</italic> (injury), and other systemic diseases</p></list-item><list-item><p>Patients with secondary insomnia</p></list-item><list-item><p>Patients on hypnotic medicine or other drugs known to cause drowsiness.</p></list-item></list>
</p></sec><sec id="sec2-3"><title>Grouping and posology</title><p>The patients were divided into two groups</p><sec id="sec3-1"><title>Tagara group</title><p>In this group, 16 patients were registered, and the study was completed with 15 patients. <italic>Tagara Churna</italic> (powder of <italic>V. wallichii</italic> rhizome) in the dose of 4 gm with milk was administered 3 times a day after food for a period of 1 month.</p></sec><sec id="sec3-2"><title>Jatamansi group</title><p>In this group, 18 patients were registered, and the study was completed with 15 patients. <italic>Jatamansi Churna</italic> (powder of <italic>N. jatamansi</italic> rhizome) in the dose of 4 gm with milk was administered 3 times a day after food for a period of 1 month.</p><p>After the completion of treatment, patients were asked to follow up study at the fortnightly interval for 1 month. Both test drugs were procured from the pharmacy attached to Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan.</p></sec></sec><sec id="sec2-4"><title>Criteria for assessment</title><p>The cardinal signs and symptoms such as difficulty in the initiation of sleep, sleep duration, disturbed sleep, and routine disturbances before and after treatment was measured by adopting Athens Insomnia Scale.[<xref rid="ref5" ref-type="bibr">5</xref>] Associated symptoms such as <italic>Angamarda</italic> (malaise), <italic>Shirogaurava</italic> (heaviness in head), <italic>Shirashoola</italic> (headache), <italic>Jrumbha</italic> (yawning), <italic>Glani</italic> (exhaustion), <italic>Bhrama</italic> (giddiness), <italic>Shrama</italic> (fatigue), and <italic>Klama</italic> (mental fatigue) were assessed by adopting scoring system according to severity of each symptom.</p></sec><sec id="sec2-5"><title>Statistical analysis</title><p>Statistical analysis was carried by using student's t- test for comparison.</p></sec><sec id="sec2-6"><title>Observations</title><p>A total of 34 patients of <italic>Anidra</italic> were studied in two groups; of which 30 patients completed the course of treatment (15 in each). The chronicity was reported up to 6 months to 1 year by 35.29%, 1&#x02013;2 years by 29.41%, 3&#x02013;6 months by 26.47%, and 2&#x02013;5 years of duration was found in 8.82% of patients. Of 34 patients, specific causative factors of <italic>Anidra</italic> that is <italic>chinta</italic> (excessive thinking) which was observed in 85.29%. Other etiological factors noted in the patients of this series were <italic>Udvega</italic> (anxiety) in 64.71%, <italic>Vishada</italic> (depression) in 29.41%, and family problems in 38.23%. Cardinal symptoms such as reduction in sleep time was present in all the patients that is, 100%, difficulty in initiation of sleep in 73.52%, disturbed sleep in 52.94%, disturbed routine work in 47.05%. Associated symptoms such as <italic>Shirogaurava</italic> was present in 64.70%, <italic>Angamarda</italic> in 61.76%, <italic>Shrama</italic> in 47.05%, <italic>Klama</italic> and <italic>Shirashula</italic> in 44.11% each, <italic>Glani</italic> in 41.17%, <italic>Aruchi</italic> (distaste) in 38.23%, <italic>Apakti</italic> (indigestion) and <italic>Jrumbha</italic> in 35.29% each, <italic>Jadyata</italic> (inactivity) and <italic>Tandra</italic> (stupor) in 29.41% each, and <italic>Bhrama</italic> in 23.52% of patients.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>The effectiveness is considered positive on the basis of established insomnia scoring scale before treatment and after the completion of 1 month of treatment.</p><p><italic>Tagara</italic> group provided a significant improvement in duration of sleep by 55.17%, in the initiation of sleep by 76.00%, in disturbed sleep by 69.58%, in disturbances in routine work by 73.95%. This difference was statistically highly significant (<italic>P</italic> &#x0003c; 0.001) [<xref ref-type="table" rid="T1">Table 1</xref>]. <italic>Jatamansi</italic> group provided 61.34% improvement in the initiation of sleep, 48.25% in the duration of sleep, 43.85% in a disturbance in routine works, and 53.08% in disturbed sleep. This improvement was statistically highly significant (<italic>P</italic> &#x0003c; 0.001) [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Effect of <italic>Tagara</italic> on sleep pattern of 15 patients of <italic>Anidra</italic> (insomnia)</p></caption><graphic xlink:href="AYU-36-46-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Effect of <italic>Jatamansi</italic> on sleep pattern of 15 patients of <italic>Anidra</italic> (insomnia)</p></caption><graphic xlink:href="AYU-36-46-g002"/></table-wrap><p><italic>Tagara</italic> provided significant relief in <italic>Angamarda</italic> (78.33%), <italic>Shirogaurava</italic> (72.60%), <italic>Shirashoola</italic> (55.83%), <italic>Jrumbha</italic> (26.41%), <italic>Glani</italic> (36.79%), <italic>Bhrama</italic> (86.02%), <italic>Shrama</italic> (80.45%), and <italic>Klama</italic> (83.33%) [<xref ref-type="table" rid="T3">Table 3</xref>]. <italic>Jatamansi</italic> also gave significant relief in <italic>Angamarda</italic> (39.16%), <italic>Shirogaurava</italic> (41.87%), <italic>Shirashoola</italic> (66.67%), <italic>Jrumbha</italic> (50.00%), <italic>Aruchi</italic> (58.75%), <italic>Shrama</italic> (45.11%), <italic>Klama</italic> (56.00%), etc. [<xref ref-type="table" rid="T4">Table 4</xref>].</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Effect of <italic>Tagara</italic> on associated symptoms of 15 patients of <italic>Anidra</italic> (insomnia)</p></caption><graphic xlink:href="AYU-36-46-g003"/></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Effect of <italic>Jatamansi</italic> on associated symptoms of 15 patients of <italic>Anidra</italic> (insomnia)</p></caption><graphic xlink:href="AYU-36-46-g004"/></table-wrap><p>While comparing the effect in between two groups of <italic>Tagara</italic> and <italic>Jatamansi</italic>, a statistical significance was present only in the symptom of disturbances in routine works whereas in the symptoms such as sleep initiation, duration of sleep, and disturbed sleep was insignificant [<xref ref-type="table" rid="T5">Table 5</xref>].</p><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Comparative effect of <italic>Tagara</italic> and <italic>Jatamansi</italic> in <italic>Anidra</italic></p></caption><graphic xlink:href="AYU-36-46-g005"/></table-wrap><p>The consideration of the overall effect of <italic>Tagara</italic> showed that, in this group, 13.3% had complete remission, 26.67% patient had marked improvement, 33.33% patients had moderate improvement, and 20.00% had mild improvement. Remaining 6.67% of patients remained unchanged. While in <italic>Jatamansi</italic> group, complete remission was found in 6.67% of patients, marked improvement in 13.33%, moderate improvement in 26.67%, and mild improvement in 40.00%; remaining 13.33% of patients remain unchanged [<xref ref-type="table" rid="T6">Table 6</xref>].</p><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>Overall effect of therapy</p></caption><graphic xlink:href="AYU-36-46-g006"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p><italic>Tamas</italic> (psychic principle) and <italic>Kapha Dosha</italic> (bodily humor) are responsible for sleep, whereas <italic>Rajas</italic> (psychic principle) and <italic>Vata Dosha</italic> (bodily humor) are responsible for loss of sleep or insomnia. <italic>Tagara</italic> and <italic>Jatamansi</italic> have similar <italic>Rasa</italic> (taste), <italic>Guna</italic> (property), and <italic>Vipaka</italic> (end product of digestion) while they differ only in <italic>Virya</italic> (potency). It is mentioned that there cannot be any <italic>Karma</italic> (action) without the help of <italic>Virya</italic> (potency).[<xref rid="ref6" ref-type="bibr">6</xref>] The <italic>Rasa</italic> (taste) of <italic>Tagara is</italic> being <italic>Katu</italic> (pungent), <italic>Tikta</italic> (bitter), <italic>Kashaya</italic> (astringent), they should probably aggravate <italic>Vata</italic> (bodily humor). However because of its <italic>Ushna Virya</italic> (hot potency), it alleviates rather than aggravate <italic>Vata</italic>. This might be the probable reason that <italic>Tagara</italic> showed a better action when compared to <italic>Jatamansi</italic>. These pharmacodynamic actions are helpful in breaking the pathogenesis of <italic>Anidra</italic>.</p><p><italic>Valerian</italic> and <italic>Nardostachys</italic> belong to the Valerianaceae family and share a group of active constituents, and the herbs are each characterized by an unusual fragrance, derived from the essential oil components. While looking into the mechanism of action of the drugs, both <italic>Tagara</italic> and <italic>Jatamansi</italic> have similar actions.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref>] Valeranone and Valepotriates are present in both the drugs, where in the percentage of the active chemical constituents are more in the case of <italic>V. wallichii</italic>. Valeranone present in <italic>Tagara</italic> is 2%[<xref rid="ref7" ref-type="bibr">7</xref>] whereas in <italic>Jatamansi</italic> it is only 0.02&#x02013;0.1%.[<xref rid="ref9" ref-type="bibr">9</xref>] Furthermore, Valepotriates are present in 3&#x02013;6% in <italic>Tagara</italic>[<xref rid="ref10" ref-type="bibr">10</xref>] whereas in <italic>Jatamansi</italic> it is less than 0.07%.[<xref rid="ref11" ref-type="bibr">11</xref>] Valepotriates are responsible for the chief effect of Valerian as a potent Sedative.[<xref rid="ref12" ref-type="bibr">12</xref>] It inhibits enzyme-induced breakdown of GABA in the brain resulting in sedation.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref>] This might be the probable reason that there was a significant improvement in the signs and symptoms of the patients.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>It is obvious from the foregoing study that <italic>Tagara</italic> and <italic>Jatamansi</italic> provided significant relief in signs and symptoms of the patients of <italic>Anidra</italic>. While comparing the results of both drugs it can be stated that <italic>Tagara</italic> provided better relief in the patients of <italic>Anidra</italic> in comparison to <italic>Jatamansi</italic>. Thus, it can be concluded that <italic>Tagara</italic> which is having the property of <italic>Nidrajanana</italic> (sedative and hypnotic) was found to be more effective in <italic>Anidra</italic> when compared to <italic>Jatamansi</italic>.</p><sec id="sec2-7"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-8"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Trikamji</surname><given-names>J</given-names></name></person-group><article-title>Agnivesha, Charaka, Dridhabala, Charaka samhita, Sutra Sthana, Ch.11, Ver. 35</article-title><year>1990</year><edition>2nd ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Sansthan</publisher-name><fpage>74</fpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Trikamji</surname><given-names>J</given-names></name></person-group><source>Agnivesha, Charaka, Dridhabala, Charaka Samhita, Sutra Sthana, Ch.21, Ver. 36</source><year>1990</year><edition>2nd ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Sansthan</publisher-name><fpage>118</fpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Namboodiri</surname><given-names>VM</given-names></name></person-group><source>Sleep and Sleep Disorders. Concise Textbook of Psychiatry</source><year>2005</year><edition>2nd ed</edition><publisher-loc>New Delhi</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>271</fpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>T</given-names></name></person-group><article-title>Insomnia: Epidemiology, characteristics, and consequences Clin Cornerstone</article-title><year>2003</year><volume>5</volume><fpage>5</fpage><lpage>15</lpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soldatos</surname><given-names>CR</given-names></name><name><surname>Dikeos</surname><given-names>DG</given-names></name><name><surname>Paparrigopoulos</surname><given-names>TJ</given-names></name></person-group><article-title>The diagnostic validity of the Athens Insomnia Scale</article-title><source>J Psychosom Res</source><year>2003</year><volume>55</volume><fpage>263</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12932801</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Trikamji</surname><given-names>J</given-names></name></person-group><article-title>Agnivesha, Charaka, Dridhabala, Charaka Samhita. Sutra Sthana, Ch. 26, Ver. 65</article-title><year>1990</year><edition>2nd ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Sansthan</publisher-name><fpage>147</fpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houghton</surname><given-names>PJ</given-names></name></person-group><article-title>The scientific basis for the reputed activity of Valerian</article-title><source>J Pharm Pharmacol</source><year>1999</year><volume>51</volume><fpage>505</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">10411208</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prabhu</surname><given-names>V</given-names></name><name><surname>Karanth</surname><given-names>KS</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name></person-group><article-title>Effects of <italic>Nardostachys jatamansi</italic> on biogenic amines and inhibitory amino acids in the rat brain</article-title><source>Planta Med</source><year>1994</year><volume>60</volume><fpage>114</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8202559</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>RK</given-names></name><name><surname>Disket</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>S</given-names></name></person-group><article-title>A review on spikenard (<italic>Nardostachys jatamansi</italic> DC.) &#x02013; An endangered essential herb of India</article-title><source>Int J Pharm Chem</source><year>2012</year><volume>2</volume><fpage>52</fpage><lpage>60</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bos</surname><given-names>R</given-names></name><name><surname>Woerdenbag</surname><given-names>HJ</given-names></name><name><surname>De Smet</surname><given-names>PAGM</given-names></name><name><surname>Keller</surname><given-names>K</given-names></name><name><surname>Haensel</surname><given-names>R</given-names></name><name><surname>Chandler</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Valeriana species</article-title><source>Adverse Effects of Herbal Drugs</source><year>1998</year><volume>3</volume><publisher-loc>Berlin</publisher-loc><publisher-name>Springer-Verlag</publisher-name><fpage>165</fpage><lpage>80</lpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dugaheh</surname><given-names>MA</given-names></name><name><surname>Meisami</surname><given-names>F</given-names></name><name><surname>Torabian</surname><given-names>Z</given-names></name><name><surname>Sharififar</surname><given-names>F</given-names></name></person-group><article-title>Antioxidant effect and study of bioactive components of <italic>Valeriana sisymbriifolia</italic> and <italic>Nardostachys jatamansi</italic> in comparison to Valeriana officinalis. Pak J Pharm Sci</article-title><year>2013</year><volume>26</volume><issue>1</issue><fpage>53</fpage><lpage>8</lpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindahl</surname><given-names>O</given-names></name><name><surname>Lindwall</surname><given-names>L</given-names></name></person-group><article-title>Double blind study of a valerian preparation</article-title><source>Pharmacol Biochem Behav</source><year>1989</year><volume>32</volume><fpage>1065</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2678162</pub-id></element-citation></ref></ref-list></back></article>